16
Participants
Start Date
May 8, 2025
Primary Completion Date
July 18, 2025
Study Completion Date
July 18, 2025
AZD2389
Oral dose on Days 5 to 13, Day 16, and Day 17. On Day 14 co-administered with a combination of midazolam and caffeine. On Day 15 co-administered with bupropion.
Midazolam
"Single oral dose on:~* Day 1 (co-administered with caffeine)~* Day 14 (co-administered with caffeine and AZD2389)"
Caffeine
"Single oral dose on:~* Day 1 (co-administered with midazolam)~* Day 14 (co-administered with midazolam and AZD2389)"
Bupropion
"Single oral dose on:~* Day 2 (alone)~* Day 15 (co-administered with AZD2389)"
Research Site, Brooklyn
Lead Sponsor
Collaborators (1)
Parexel
INDUSTRY
AstraZeneca
INDUSTRY